octamethylcyclotetrasiloxane

We are octamethylcyclotetrasiloxane CAS:556-67-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Chemical Name:octamethylcyclotetrasiloxane
CAS.NO:556-67-2
Synonyms:Octamethylcyclotetrasiloxane; Cyclotetrasiloxane, octamethyl-; 2,2,4,4,6,6,8,8-octamethyl-1,3,5,7,2,4,6,8-tetraoxatetrasilocane;
Molecular Formula:C8H24O4Si4
Molecular Weight:296.61600
 
Physical and Chemical Properties:
Density:0.956;
Melting point:17-18^oC;
Boiling point:175-176^oC;
Flash point:140^oF;
Index of Refraction:1.3968;
 
Specification:
Appearance:Colorless clear liquid
Purity(GC):≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It is a cyclic organic silicon substance which can be used as monomer in the production of silicone polymers such as rubber, resins and greases.




Related News: The upstream of pharmaceutical intermediates is the basic chemical raw material industry. Basic chemical raw materials are bulk commodities and prices fluctuate greatly, which directly affects the production costs of enterprises.1-cloro-5-fluoropentano CAS:407-98-7 Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.fenil N- [4- [4- (4-hidroxifenil) piperazin-1-il] fenil] carbamato CAS:184177-81-9 The iLet is designed to function as three medical devices in one. It can be configured as an insulin-only bionic pancreas, a glucagon-only bionic pancreas, or a bihormonal bionic pancreas using insulin and glucagon.Cis-1,2,3,6-Tetrahydrophthalic Anhydride The iLet is designed to function as three medical devices in one. It can be configured as an insulin-only bionic pancreas, a glucagon-only bionic pancreas, or a bihormonal bionic pancreas using insulin and glucagon.Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.